Singapore, March 27 -- The Health Sciences Authority received information related to the study titled 'PODOMOUNT-Basket, a Phase II, multicentre, randomised, 2 arm parallel-group, double-blind, placebo-controlled basket trial to assess safety, tolerability, PK, and efficacy of BI 764198 in four proteinuric kidney diseases'. The following are the other relevant details related to the trial:
Therapeutic Area: Renal Medicine
Trial Centre(s):
Singapore General Hospital
Tan Tock Seng Hospital
Trial Status: NA
Principal Investigator(s):
Dr Lee Tung Lin
Dr Yeo See Cheng
Published by HT Digital Content Services with permission from Health Daily Digest....